ConforMIS Inc. (CFMS) Trading Up 3%
ConforMIS Inc. (NASDAQ:CFMS)’s share price was up 3% during mid-day trading on Friday . The stock traded as high as $8.12 and last traded at $7.94, with a volume of 156,796 shares. The stock had previously closed at $7.71.
Several equities analysts recently issued reports on CFMS shares. Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $12.00 target price (down previously from $18.00) on shares of ConforMIS in a research note on Tuesday, May 17th. Zacks Investment Research lowered ConforMIS from a “hold” rating to a “sell” rating in a research report on Tuesday, June 7th. JPMorgan Chase & Co. lowered ConforMIS from an “overweight” rating to a “neutral” rating and reduced their price target for the company from $18.00 to $8.00 in a research report on Friday, May 13th. Canaccord Genuity reaffirmed a “buy” rating on shares of ConforMIS in a research report on Saturday, May 14th. Finally, Wells Fargo & Co. lowered ConforMIS from an “outperform” rating to a “market perform” rating in a research report on Friday, May 13th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $15.40.
The firm’s market cap is $344.56 million. The company’s 50-day moving average price is $7.15 and its 200-day moving average price is $9.04.
ConforMIS (NASDAQ:CFMS) last announced its quarterly earnings data on Monday, August 8th. The company reported ($0.34) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.35) by $0.01. The business earned $19.30 million during the quarter, compared to analysts’ expectations of $18.02 million. During the same period in the prior year, the firm earned ($2.51) EPS. ConforMIS’s revenue for the quarter was up .5% on a year-over-year basis. Analysts forecast that ConforMIS Inc. will post ($1.41) earnings per share for the current year.
A hedge fund recently raised its stake in ConforMIS stock. RS Investment Management Co. LLC boosted its position in shares of ConforMIS Inc. (NASDAQ:CFMS) by 3.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,432,470 shares of the company’s stock after buying an additional 43,490 shares during the period. RS Investment Management Co. LLC owned about 3.52% of ConforMIS worth $24,767,000 at the end of the most recent reporting period.
ConforMIS, Inc is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.